Subtype-specific differences in subcellular localization and chlorethylclonidine inactivation of alpha1-adrenoceptors
- PMID: 9585137
- DOI: 10.1016/s0024-3205(98)00108-8
Subtype-specific differences in subcellular localization and chlorethylclonidine inactivation of alpha1-adrenoceptors
Abstract
Chlorethylclonidine (CEC) inactivation has been used as one criterion to subclassify the alpha1-adrenoceptors (AR); however, the extent of CEC inactivation can vary depending on the CEC treatment. By constructing the FLAG-tagged (N-terminus) and green fluorescent protein (GFP)-fused (C-terminus) alpha1-ARs, we have determined the relationship between CEC sensitivity and the cellular localization of alpha1-AR subtypes using COS-7 cells. In GFP-expressing cells, flow cytometry analysis with anti-FLAG N-terminus antibody detected strong fluorescent signals in most of alpha1B-AR-expressing cells, but low signals in alpha1A-AR-expressing cells. Further examination with confocal microscopy showed that fluorescent signals densely localized intra-cellularly in alpha1A-AR-expressing cells, while most of alpha1B-AR localized on the cell surface. Furthermore, radioligand binding studies with [125I]HEAT showed that CEC (10 microM) treatment of intact cells inactivated approximately 30-40% of alpha1A-AR and >90% of alpha1B-AR, while the CEC treatment of membrane preparations resulted in >80% decrease in the alpha1A-AR density and >90% of alpha1B-AR density, respectively. The results showed that the hydrophilic alkylating agent CEC inactivated only alpha1-AR on the cell surface irrespective of its subtype, and that the subtype-specific sorting is a major determinant for CEC inactivation of alpha1-AR. Subtype-specific cellular localization suggests a new class of functional properties that may explain the signal and functional diversity of homologous alpha1-AR (as well as other G protein-coupled receptors) subtypes.
Similar articles
-
Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype.Mol Pharmacol. 1997 Nov;52(5):764-70. doi: 10.1124/mol.52.5.764. Mol Pharmacol. 1997. PMID: 9351966
-
Differences in the subcellular localization of alpha1-adrenoceptor subtypes can affect the subtype selectivity of drugs in a study with the fluorescent ligand BODIPY FL-prazosin.Life Sci. 2002 Mar 22;70(18):2113-24. doi: 10.1016/s0024-3205(01)01533-8. Life Sci. 2002. PMID: 12002804
-
Rat pineal alpha 1-adrenoceptor subtypes: studies using radioligand binding and reverse transcription-polymerase chain reaction analysis.Br J Pharmacol. 1996 Jul;118(5):1246-52. doi: 10.1111/j.1476-5381.1996.tb15530.x. Br J Pharmacol. 1996. PMID: 8818350 Free PMC article.
-
Recent progress in alpha1-adrenergic receptor research.Acta Pharmacol Sin. 2005 Nov;26(11):1281-7. doi: 10.1111/j.1745-7254.2005.00224.x. Acta Pharmacol Sin. 2005. PMID: 16225747 Review.
-
Alpha1-adrenoceptor subtypes.Eur J Pharmacol. 1999 Jun 30;375(1-3):261-76. doi: 10.1016/s0014-2999(99)00222-8. Eur J Pharmacol. 1999. PMID: 10443582 Review.
Cited by
-
Interaction of Norepinephrine and Glucocorticoids Modulate Inhibition of Principle Cells of Layer II Medial Entorhinal Cortex in Male Mice.Front Synaptic Neurosci. 2018 Mar 28;10:3. doi: 10.3389/fnsyn.2018.00003. eCollection 2018. Front Synaptic Neurosci. 2018. PMID: 29643800 Free PMC article.
-
The alpha1D-adrenergic receptor is expressed intracellularly and coupled to increases in intracellular calcium and reactive oxygen species in human aortic smooth muscle cells.J Mol Signal. 2008 Feb 27;3:6. doi: 10.1186/1750-2187-3-6. J Mol Signal. 2008. PMID: 18304336 Free PMC article.
-
Hepatocytes from alpha1B-adrenoceptor knockout mice reveal compensatory adrenoceptor subtype substitution.Br J Pharmacol. 2004 Jul;142(6):1031-7. doi: 10.1038/sj.bjp.0705872. Epub 2004 Jun 21. Br J Pharmacol. 2004. PMID: 15210583 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials